Terms: = Leukemia AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
10 results:
1. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by rita treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract] [Full Text] [Related]
2. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract] [Full Text] [Related]
3. rita induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
[TBL] [Abstract] [Full Text] [Related]
4. rita enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract] [Full Text] [Related]
5. rita inhibits multiple myeloma cell growth through induction of p53-mediated caspase-dependent apoptosis and synergistically enhances nutlin-induced cytotoxic responses.
Saha MN; Jiang H; Mukai A; Chang H
Mol Cancer Ther; 2010 Nov; 9(11):3041-51. PubMed ID: 21062913
[TBL] [Abstract] [Full Text] [Related]
6. Ablation of key oncogenic pathways by rita-reactivated p53 is required for efficient apoptosis.
Grinkevich VV; Nikulenkov F; Shi Y; Enge M; Bao W; Maljukova A; Gluch A; Kel A; Sangfelt O; Selivanova G
Cancer Cell; 2009 May; 15(5):441-53. PubMed ID: 19411072
[TBL] [Abstract] [Full Text] [Related]
7. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms.
McHale CM; Zhang L; Lan Q; Li G; Hubbard AE; Forrest MS; Vermeulen R; Chen J; Shen M; Rappaport SM; Yin S; Smith MT; Rothman N
Genomics; 2009 Apr; 93(4):343-9. PubMed ID: 19162166
[TBL] [Abstract] [Full Text] [Related]
8. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract] [Full Text] [Related]
9. Progress of epidemiological and molecular epidemiological studies on benzene in China.
Li G; Yin S
Ann N Y Acad Sci; 2006 Sep; 1076():800-9. PubMed ID: 17119257
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers.
Forrest MS; Lan Q; Hubbard AE; Zhang L; Vermeulen R; Zhao X; Li G; Wu YY; Shen M; Yin S; Chanock SJ; Rothman N; Smith MT
Environ Health Perspect; 2005 Jun; 113(6):801-7. PubMed ID: 15929907
[TBL] [Abstract] [Full Text] [Related]
